From genetics to functional insights into rheumatoid arthritis

Area of Science:

• Immunology
• Genetics
• Rheumatology

Background:

• Rheumatoid Arthritis (RA) is a prevalent systemic autoimmune disease affecting 0.5%-1% globally.
• RA pathogenesis involves synovial inflammation, pannus formation, and subsequent joint destruction.
• Genetic and environmental factors contribute to RA, with susceptibility genes identified via GWAS.

Purpose of the Study:

• To elucidate the role of the Peptidylarginine deiminase type 4 (PADI4) gene in Rheumatoid Arthritis pathogenesis.
• To investigate the association between PADI4 genetic variations and RA development.
• To understand the functional consequences of RA-associated PADI4 SNPs on gene expression and disease pathology.

Main Methods:

• Genome-wide association studies (GWAS) to identify RA susceptibility loci.
• Analysis of single nucleotide polymorphisms (SNPs) within the PADI4 coding region.
• Assessment of allelically imbalanced gene expression related to RA-associated SNPs.

Main Results:

• PADI4 identified as a key RA susceptibility gene.
• Specific SNPs in PADI4 are significantly associated with Rheumatoid Arthritis.
• RA-associated PADI4 SNPs lead to allelically imbalanced gene expression with pathological implications.
• PADI4 catalyzes the conversion of peptidylarginine to peptidylcitrulline, generating citrulline epitopes targeted by RA autoantibodies.

Conclusions:

• Genetic variations in PADI4 contribute to Rheumatoid Arthritis susceptibility.
• Understanding the physiological significance of susceptibility genes like PADI4 is crucial for comprehending RA pathogenesis.
• The interplay of multiple genetic factors and their pathway effects is essential for RA development.